Electroacupuncture intervention for gastrointestinal dysfunction after chemotherapy in colorectal cancer: a randomized controlled trial
- Conditions
- Colorectal cancer
- Registration Number
- ITMCTR2200006415
- Lead Sponsor
- Chengdu University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) The age is 18 years old = age = 75 years old, male or female;
(2) The diagnosis of primary colon cancer or primary high rectal cancer was confirmed by colonoscopy and histopathological biopsy;
(3) At least one cycle of chemotherapy has been completed, and symptoms related to gastrointestinal dysfunction, including nausea, vomiting, abdominal distension, diarrhea, constipation, etc., have been completed after chemotherapy; any item in the gastrointestinal symptom grading scale has a score of 2 or more .
(4) Karnofsky score = 60 points, or ECOG physical condition score = 1 point;
(5) Have not received acupuncture and moxibustion in the past 3 months and have not participated in other clinical investigators in the past 3 months;
(6) Gastrointestinal dysfunction caused by non-opioid drugs or metabolic imbalance;
(7) Sign the informed consent form and voluntarily participate in this researcher.
(1) Those who have undergone total colorectal resection;
(2) Combined with severe heart and cerebrovascular diseases;
(3) Combined with abnormal coagulation function;
(4) Consciousness is unclear, unable to express subjective discomfort symptoms and mentally ill patients;
(5) Long-term use of laxatives, or taking drugs that affect gastrointestinal function and long-term bed rest.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gastrointestinal symptom rating scale;
- Secondary Outcome Measures
Name Time Method Patient Self-Reported Outcomes;SDS (Self-Rating Depression Scale);SAS (Self-Rating Anxiety Scale);Evaluation of the Functional Assessment of Cancer Therapy-Colorectal (V4.0);